Journal
PHARMACEUTICAL RESEARCH
Volume 25, Issue 4, Pages 740-751Publisher
SPRINGER/PLENUM PUBLISHERS
DOI: 10.1007/s11095-007-9396-z
Keywords
apoptosis and disease; apoptosis induction; apoptosis inhibition; apoptosome regulation
Funding
- Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom
- Telethon [TCR04004] Funding Source: Medline
Ask authors/readers for more resources
Apoptosis plays a crucial role in tissue homeostasis, development and many diseases. The relevance of Apaf1, the molecular core of apoptosome, has been underlined in mitochondria-dependent apoptosis, which according to a growing body of evidence, is involved in various pathologies where the equilibrium of life-and-death is dysregulated, such as heart attack, stroke, liver failure, cancer and autoimmune diseases. Consequently, great interest has emerged in devising therapeutic strategies for regulating the key molecules involved in the life-and-death decision. Here we review recent progress in apoptosis-based pharmacological therapies and, in particular, we point out a possible role of the apoptosome as an emerging and promising pharmacological target.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available